The Challenge of Assessing Adherence to Subcutaneous Biological Drugs in Immune-Mediated Inflammatory Diseases. Letter to the Editor Regarding Michetti P, Weinman J, Mrowietz U, et al. Adv Ther (2017);34:91 –108. doi:10.1007/s12325-016-0441-3
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Drugs & Pharmacology